Safety and Dose-finding Study of DC-TAB in Healthy Subjects
NCT02442557
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
76
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Sclerosis
Interventions
BIOLOGICAL:
recombinant human alpha B-crystallin
OTHER:
placebo comparator
Sponsor
Delta Crystallon BV